Initial Treatment for DVT in Patients with Factor V Leiden

Initial Anticoagulation Options

The American College of Chest Physicians suggests low-molecular-weight heparin (LMWH) over intravenous unfractionated heparin (IV UFH) (Grade 2C) and over subcutaneous unfractionated heparin (SC UFH) (Grade 2B) due to its more predictable pharmacokinetics and reduced need for monitoring 1, 2
Fondaparinux is another option, particularly when LMWH is not available or contraindicated 1, 3
IV UFH is typically given using a weight-based dosing algorithm (80 U/kg bolus followed by 18 U/kg per hour) with dose adjustment to maintain an activated partial thromboplastin time ratio of 1.5 to 2.5 1
Rivaroxaban can be used as monotherapy without initial parenteral anticoagulation (15 mg twice daily for 21 days and then 20 mg once daily) 1, 2

For patients with high clinical suspicion of DVT, treatment with parenteral anticoagulants is suggested while awaiting diagnostic test results (Grade 2C) 2, 4
For intermediate clinical suspicion, parenteral anticoagulation is suggested if diagnostic test results will be delayed more than 4 hours (Grade 2C) 4
For low clinical suspicion, withholding anticoagulation is suggested if test results are expected within 24 hours (Grade 2C) 4

If using vitamin K antagonist (VKA) therapy, early initiation is recommended on the same day as parenteral therapy is started 3, 4
Parenteral anticoagulation should be continued for a minimum of 5 days and until the INR is ≥2.0 for at least 24 hours (Grade 1B) 3, 4

In patients with acute DVT of the leg and adequate home circumstances, initial treatment at home is recommended over treatment in hospital (Grade 1B) 3

Avoid using LMWH in patients with severe renal impairment (CrCl <30 mL/min) due to risk of drug accumulation 1
Fondaparinux is contraindicated in patients with CrCl <30 mL/min 1
When using warfarin in patients with factor V Leiden, consider lower starting doses in elderly patients, those with poor nutritional status, or those taking medications that affect warfarin metabolism 1
Avoid warfarin in patients with moderate-to-severe liver disease or hepatic coagulopathy 1
For patients with DVT and factor V Leiden who have a contraindication to anticoagulation, an inferior vena cava (IVC) filter is recommended (Grade 1B) 3